comagis cream
padagis israel pharmaceuticals ltd, israel - bifonazole; fluocinonide - cream - fluocinonide 0.05 w/w; bifonazole 1.00 w/w - bifonazole - bifonazole - broad-spectrum drug for relief of inflammatory conditions accompanied by fungal infection, which respond to corticoid therapy.
mentax cream
padagis israel pharmaceuticals ltd, israel - butenafine hydrochloride - cream - butenafine hydrochloride 1 % - butenafine - butenafine - interdigital tinea pedis, tinea coporis, tinea cruris . (treatment in tinea coporis and tinea cruris is limited to up to 4 weeks).
agisten v 2 % vaginal cream
padagis israel pharmaceuticals ltd, israel - clotrimazole - vaginal cream - clotrimazole 2 % - clotrimazole - clotrimazole - broad spectrum antimycotic with fungicidal action
endometrin
ferring pharmaceuticals ltd - progesterone - vaginal tablets - progesterone 100 mg - progesterone - progesterone - progesterone supplementation or replacement in cases such as treatment of infertile women and ivf.
trisenox
medison pharma ltd - arsenic trioxide - solution for injection - arsenic trioxide 1 mg/ml - arsenic trioxide - arsenic trioxide - trisenox is indicated for induction of remission, and consolidation in adult patients with:• newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 1000/μl) in combination with all-trans-retinoic acid (atra)• relapsed/refractory acute promyelocytic leukaemia (apl)(previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rar-alpha) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.
profiten syrup
padagis israel pharmaceuticals ltd, israel - ketotifen as fumarate - syrup - ketotifen as fumarate 1 mg / 5 ml - other antihistamines for systemic use - prophylactic treatment of bronchial asthma. symptomatic treatment of allergic conditions including bronchitis, rhinitis, hay fever and urticaria.
clarithromycin martindale pharma 500 mg powder for concentrate for solution for infusion
martindale pharmaceuticals ltd - clarithromycin - pdr/conc/soln for infus - 500 milligram(s) - macrolides; clarithromycin
risperidone 1mg/ml oral solution
rosemont pharmaceuticals ltd - risperidone - oral solution - 1mg/ml - other antipsychotics - it is indicated for the treatment of schizophrenia; for the treatment of moderate to severe manic episodes associated with bipolar disorders; for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.; for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to dsm-iv criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment.
carbamazepine essential pharma
essential pharma ltd - carbamazepine - suppositories - 125 milligram - carbamazepine
carbamazepine essential pharma
essential pharma ltd - carbamazepine - suppositories - 250 milligram - carbamazepine